Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation

Stella Ling, Aashish D. Bhatt, Nicole V. Brown, Phuong Nguyen, Jennifer A. Sipos, Arnab Chakravarti, Yi Rong

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Thyroid dysfunction is common after radiotherapy (RT) for patients with head and neck cancers. We attempted to discover RT dose parameters that correspond with RT-induced thyroid dysfunction. Methods: Records of 102 patients who received RT from 2008 to 2010 were reviewed with respect to thyroid function. Abnormalities were grouped in 2 ways: (1) none, transient, or permanent; and (2) overt or subclinical. Results: At median follow-up of 33.5 months, incidence of any thyroid abnormality was 39.2% (women vs men – 50% vs 35%). Permanent dysfunction was seen in 24.5% with higher incidence in women versus men (42.9% vs 17.6%; p =.0081). Permanent abnormalities most strongly correlated with D50% (p =.0275). V50Gy also correlated with thyroid dysfunction post-RT (p =.0316). Concurrent chemotherapy increased permanent dysfunction (p =.0008). Conclusion: Achieving D50% <50 Gy, V50 <50%, and mean dose <54.58 Gy during RT planning may decrease the incidence; whereas female sex and concurrent chemotherapy seem to increase the risk of RT-induced hypothyroidism.

Original languageEnglish (US)
Pages (from-to)548-554
Number of pages7
JournalHead and Neck
Volume39
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Thyroid Gland
Neck
Radiotherapy
Head
Radiation
Incidence
Drug Therapy
Head and Neck Neoplasms
Hypothyroidism

Keywords

  • head and neck radiotherapy
  • hypothyroidism
  • radiation dose volume histogram (DVH)
  • radiation toxicity
  • thyroid abnormality

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation. / Ling, Stella; Bhatt, Aashish D.; Brown, Nicole V.; Nguyen, Phuong; Sipos, Jennifer A.; Chakravarti, Arnab; Rong, Yi.

In: Head and Neck, Vol. 39, No. 3, 01.03.2017, p. 548-554.

Research output: Contribution to journalArticle

Ling, S, Bhatt, AD, Brown, NV, Nguyen, P, Sipos, JA, Chakravarti, A & Rong, Y 2017, 'Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation', Head and Neck, vol. 39, no. 3, pp. 548-554. https://doi.org/10.1002/hed.24643
Ling, Stella ; Bhatt, Aashish D. ; Brown, Nicole V. ; Nguyen, Phuong ; Sipos, Jennifer A. ; Chakravarti, Arnab ; Rong, Yi. / Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation. In: Head and Neck. 2017 ; Vol. 39, No. 3. pp. 548-554.
@article{bdbd4070df2e4ad3ba6234dd82a5b00c,
title = "Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation",
abstract = "Background: Thyroid dysfunction is common after radiotherapy (RT) for patients with head and neck cancers. We attempted to discover RT dose parameters that correspond with RT-induced thyroid dysfunction. Methods: Records of 102 patients who received RT from 2008 to 2010 were reviewed with respect to thyroid function. Abnormalities were grouped in 2 ways: (1) none, transient, or permanent; and (2) overt or subclinical. Results: At median follow-up of 33.5 months, incidence of any thyroid abnormality was 39.2{\%} (women vs men – 50{\%} vs 35{\%}). Permanent dysfunction was seen in 24.5{\%} with higher incidence in women versus men (42.9{\%} vs 17.6{\%}; p =.0081). Permanent abnormalities most strongly correlated with D50{\%} (p =.0275). V50Gy also correlated with thyroid dysfunction post-RT (p =.0316). Concurrent chemotherapy increased permanent dysfunction (p =.0008). Conclusion: Achieving D50{\%} <50 Gy, V50 <50{\%}, and mean dose <54.58 Gy during RT planning may decrease the incidence; whereas female sex and concurrent chemotherapy seem to increase the risk of RT-induced hypothyroidism.",
keywords = "head and neck radiotherapy, hypothyroidism, radiation dose volume histogram (DVH), radiation toxicity, thyroid abnormality",
author = "Stella Ling and Bhatt, {Aashish D.} and Brown, {Nicole V.} and Phuong Nguyen and Sipos, {Jennifer A.} and Arnab Chakravarti and Yi Rong",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/hed.24643",
language = "English (US)",
volume = "39",
pages = "548--554",
journal = "Head and Neck Surgery",
issn = "0148-6403",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Correlative study of dose to thyroid and incidence of subsequent dysfunction after head and neck radiation

AU - Ling, Stella

AU - Bhatt, Aashish D.

AU - Brown, Nicole V.

AU - Nguyen, Phuong

AU - Sipos, Jennifer A.

AU - Chakravarti, Arnab

AU - Rong, Yi

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background: Thyroid dysfunction is common after radiotherapy (RT) for patients with head and neck cancers. We attempted to discover RT dose parameters that correspond with RT-induced thyroid dysfunction. Methods: Records of 102 patients who received RT from 2008 to 2010 were reviewed with respect to thyroid function. Abnormalities were grouped in 2 ways: (1) none, transient, or permanent; and (2) overt or subclinical. Results: At median follow-up of 33.5 months, incidence of any thyroid abnormality was 39.2% (women vs men – 50% vs 35%). Permanent dysfunction was seen in 24.5% with higher incidence in women versus men (42.9% vs 17.6%; p =.0081). Permanent abnormalities most strongly correlated with D50% (p =.0275). V50Gy also correlated with thyroid dysfunction post-RT (p =.0316). Concurrent chemotherapy increased permanent dysfunction (p =.0008). Conclusion: Achieving D50% <50 Gy, V50 <50%, and mean dose <54.58 Gy during RT planning may decrease the incidence; whereas female sex and concurrent chemotherapy seem to increase the risk of RT-induced hypothyroidism.

AB - Background: Thyroid dysfunction is common after radiotherapy (RT) for patients with head and neck cancers. We attempted to discover RT dose parameters that correspond with RT-induced thyroid dysfunction. Methods: Records of 102 patients who received RT from 2008 to 2010 were reviewed with respect to thyroid function. Abnormalities were grouped in 2 ways: (1) none, transient, or permanent; and (2) overt or subclinical. Results: At median follow-up of 33.5 months, incidence of any thyroid abnormality was 39.2% (women vs men – 50% vs 35%). Permanent dysfunction was seen in 24.5% with higher incidence in women versus men (42.9% vs 17.6%; p =.0081). Permanent abnormalities most strongly correlated with D50% (p =.0275). V50Gy also correlated with thyroid dysfunction post-RT (p =.0316). Concurrent chemotherapy increased permanent dysfunction (p =.0008). Conclusion: Achieving D50% <50 Gy, V50 <50%, and mean dose <54.58 Gy during RT planning may decrease the incidence; whereas female sex and concurrent chemotherapy seem to increase the risk of RT-induced hypothyroidism.

KW - head and neck radiotherapy

KW - hypothyroidism

KW - radiation dose volume histogram (DVH)

KW - radiation toxicity

KW - thyroid abnormality

UR - http://www.scopus.com/inward/record.url?scp=85006166559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006166559&partnerID=8YFLogxK

U2 - 10.1002/hed.24643

DO - 10.1002/hed.24643

M3 - Article

VL - 39

SP - 548

EP - 554

JO - Head and Neck Surgery

JF - Head and Neck Surgery

SN - 0148-6403

IS - 3

ER -